Canada Pension Plan Investment Board
ARRY

Canada Pension Plan Investment Board’s Array Biopharma Inc ARRY Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-596,114
Closed -$27.6M – 1351
2019
Q2 		$27.6M Sell
596,114
-120,972
-17% -$3.4M 0.06% 273
2019
Q1 		$17.5M Sell
717,086
-11,414
-2% -$238K 0.03% 426
2018
Q4 		$10.4M Sell
728,500
-190,200
-21% -$2.89M 0.02% 561
2018
Q3 		$14M Buy
918,700
+27,800
+3% +$426K 0.03% 513
2018
Q2 		$14.9M Buy
890,900
+429,300
+93% +$6.83M 0.03% 455
2018
Q1 		$7.53M Buy
461,600
+292,000
+172% +$4.68M 0.01% 682
2017
Q4 		$2.17M Buy
169,600
+157,600
+1,313% +$1.79M ﹤0.01% 874
2017
Q3 		$148K Sell
12,000
-124,000
-91% -$1.15M ﹤0.01% 1055
2017
Q2 		$1.14M Sell
136,000
-814,500
-86% -$6.66M ﹤0.01% 910
2017
Q1 		$8.5M Buy
+950,500
New +$10.1M 0.02% 494

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Canada Pension Plan Investment Board's ARRY Position: Q3 2019 in Review

Canada Pension Plan Investment Board sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 596,114 shares — an estimated $27.6M sold.

Canada Pension Plan Investment Board first reported a position in ARRY in Q1 2017 and held it in 10 quarters. The position peaked at $27.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Canada Pension Plan Investment Board reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 596,114 Array Biopharma Inc shares in Q3 2019, an estimated $27.6M.
  • Canada Pension Plan Investment Board first reported a position in Array Biopharma Inc in Q1 2017 and held it in 10 quarters.
  • Canada Pension Plan Investment Board's Array Biopharma Inc position peaked at $27.6M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2019, filed 12 Nov 2019.